Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells

Cell Metabolism

Volumn 10, Issue 2, 2009, Pages 139-147

  Idris, Aymen I ^a   Sophocleous, Antonia ^a   Landao Bassonga, Euphemie ^a   Canals, Meritxell ^b   Milligan, Graeme ^b   Baker, David ^c   van't Hof, Robert J ^a   Ralston, Stuart H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

HUMDISEASE; SIGNALING

Indexed keywords

CANNABINOID 1 RECEPTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MASS; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STROMA CELL; WILD TYPE;

ADIPOCYTES; ANIMALS; BONE DENSITY; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOPOROSIS; PPAR GAMMA; RECEPTOR, CANNABINOID, CB1; STROMAL CELLS;

MUS;

EID: 67849129193     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.07.006     Document Type: Article

References (32)

1. Ali A.A., Weinstein R.S., Stewart S.A., Parfitt A.M., Manolagas S.C., and Jilka R.L. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146 (2005) 1226-1235
2. Beamer W.G., Donahue L.R., Rosen C.J., and Baylink D.J. Genetic variability in adult bone density among inbred strains of mice. Bone 18 (1996) 397-403
3. Cao Z., Umek R.M., and McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5 (1991) 1538-1552
4. Demuth D.G., and Molleman A. Cannabinoid signalling. Life Sci. 78 (2006) 549-563
5. Eriksen E.F., Mosekilde L., and Melsen F. Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone 6 (1985) 141-146
6. Fox K.E., Fankell D.M., Erickson P.F., Majka S.M., Crossno Jr. J.T., and Klemm D.J. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J. Biol. Chem. 281 (2006) 40341-40353
7. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., and Nuttall M.E. Playing with bone and fat. J. Cell. Biochem. 98 (2006) 251-266
8. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
9. Idris A.I., van 't Hof R.J., Greig I.R., Ridge S.A., Baker D., Ross R.A., and Ralston S.H. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat. Med. 11 (2005) 774-779
10. Idris A.I., Rojas J., Greig I.R., Van't Hof R.J., and Ralston S.H. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif. Tissue Int. 82 (2008) 191-201
11. Idris A.I., Sophocleous A., Landao-Bassonga E., van't Hof R.J., and Ralston S.H. Regulation of bone mass, osteoclast function and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology 149 (2008) 5619-5626
12. Justesen J., Stenderup K., Ebbesen E.N., Mosekilde L., Steiniche T., and Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2 (2001) 165-171
13. Justesen J., Stenderup K., Eriksen E.F., and Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif. Tissue Int. 71 (2002) 36-44
14. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
15. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Böhme G.A., Imperato A., Pedrazzini T., Roques B.P., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
16. Lips P., Courpron P., and Meunier P.J. Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif. Tissue Res. 26 (1978) 13-17
17. Merkouris M., Mullaney I., Georgoussi Z., and Milligan G. Regulation of spontaneous activity of the delta-opioid receptor: studies of inverse agonism in intact cells. J. Neurochem. 69 (1997) 2115-2122
18. Meunier P., Aaron J., Edouard C., and Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 80 (1971) 147-154
19. Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., Tam J., Attar-Namdar M., Kram V., Shohami E., et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc. Natl. Acad. Sci. USA 103 (2006) 696-701
20. Pertwee R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6 (1999) 635-664
21. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115 (2005) 3318-3325
22. Ravinet T.C., Delgorge C., Menet C., Arnone M., and Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 640-648
23. Reusch J.E., Colton L.A., and Klemm D.J. CREB activation induces adipogenesis in 3T3-L1 cells. Mol. Cell. Biol. 20 (2000) 1008-1020
24. Riggs B.L., Wahner H.W., Seeman E., Offord K.P., Dunn W.L., Mazess R.B., Johnson K.A., and Melton III L.J. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J. Clin. Invest. 70 (1982) 716-723
25. Rzonca S.O., Suva L.J., Gaddy D., Montague D.C., and Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145 (2004) 401-406
26. Stewart T.L., Roschger P., Misof B.M., Mann V., Fratzl P., Klaushofer K., Aspden R.M., and Ralston S.H. Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralisation in vivo. Calcif. Tissue Int. 77 (2005) 113-118
27. Tam J., Trembovler V., Di Marzo V., Petrosino S., Leo G., Alexandrovich A., Regev E., Casap N., Shteyer A., Ledent C., et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J. 22 (2008) 285-294
28. Tintut Y., Parhami F., Le V., Karsenty G., and Demer L.L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 274 (1999) 28875-28879
29. van't Hof R.J. Osteoclast formation in the mouse coculture assay. In: Helfrich M.H., and Ralston S.H. (Eds). Bone Research Protocols (2003), Humana Press, Totowa 145-152
30. Verma S., Rajaratnam J.H., Denton J., Hoyland J.A., and Byers R.J. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55 (2002) 693-698
31. Yajima Y., Akita Y., and Saito T. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells. J. Biol. Chem. 261 (1986) 2684-2689
32. Yang D.C., Tsay H.J., Lin S.Y., Chiou S.H., Li M.J., Chang T.J., and Hung S.C. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS ONE 3 (2008) e1540